≥99% HPLCPre-filled pen

Bronchogen

Name: Bronchogen
Brand: Dripfy
Availability: InStock

What it is?

Bronchogen is an organ-targeted peptide bioregulator positioned to support lung tissue function and respiratory resilience. It is studied within frameworks focused on tissue maintenance, recovery capacity, and functional stability of the respiratory system.

Dripfy Advantage

Tissue-specific signalling orientation: Designed for lung-tissue support, aligning with organ-focused regulatory peptide frameworks.
Protein synthesis regulation: Positioned to influence protein synthesis dynamics in lung tissue cells, supporting structural maintenance and function.
Functional restoration pathways: Associated with signalling relevant to restoring and maintaining normal respiratory tissue function markers.
Resilience under stress: Often framed for protocols examining recovery from environmental load or respiratory stressors.

Clinical Applications & Therapeutic Potential

Respiratory function endpoints: Potential support for lung-function stability markers and overall respiratory performance parameters.
Tissue maintenance and recovery: Positioned for lung-tissue recovery and maintenance endpoints, especially in prolonged stress contexts.
Resilience frameworks: Potential benefits for protocols targeting respiratory resilience under environmental challenges (context-dependent).
Healthspan relevance: Supports long-term organ-function preservation strategies within ageing and vitality frameworks.

Composition & Formulation

Class: Organ-specific bioregulatory peptide (lung tissue bioregulator class)
Format: Ready-to-use pre-filled pen

€413

Order by email

Submit an enquiry and we arrange the consultation, physician review and shipping. Physician recommendation required; not medical advice.

Purity: ≥99%
Form: Pre-filled pen
Download Certificate of Analysis: Certificate of Analysis available on request

Important medical notice

A physician recommendation is mandatory before use.
The information on this website is educational only and is not medical advice, diagnosis, or treatment.
Always consult a qualified physician before starting any peptide.
Dosing is individualised and determined by your treating physician.

Peptide Practice Guide

Each card summarises what the peptide is studied for and its evidence strength. It is not a recommendation. Dosing and suitability are decided by your physician.

Bronchogen

Investigational lung-directed peptide bioregulator (Khavinson-type) · Pre-filled pen

D· Preliminary evidence

Bronchogen is a short peptide from the Khavinson family of tissue-directed 'bioregulators', proposed to influence gene expression and protein-synthesis signalling in respiratory-tissue cells. The concept under study is that organ-specific peptides may help maintain normal lung-cell activity, but supporting data are largely preclinical and mechanistic. Its relevance to human respiratory ageing remains unproven.

Studied use areas

Respiratory-tissue maintenance signalling (research interest)
Protein-synthesis regulation in lung cells
Recovery capacity after environmental or respiratory stress (investigational)
Age-related respiratory function decline (exploratory framework)

Safety & status

Investigational bioregulator without established human safety data; use only under physician supervision
Not approved as a medicine by EMA or MHRA
Respiratory symptoms require proper medical evaluation rather than self-directed peptide use

⚕ Clinical note: This is educational information only and not medical advice. Bronchogen is investigational; any use should be individualised and determined by a treating physician under appropriate supervision.

Evidence: Grade D — investigational; mechanistic and small-model data only, with no robust human clinical trials. · References: Peer-reviewed peptide-bioregulator (Khavinson) research literature; General respiratory physiology and cell-biology reviews; EMA/MHRA guidance on unlicensed investigational substances